Verona Pharma plc (VRP.L) (VRP) Share Forecast, Price & News

Verona Pharma plc (VRP.L) (LON:VRP) Frequently Asked Questions

How were Verona Pharma plc (VRP.L)'s earnings last quarter?

Verona Pharma plc (VRP.L) (LON:VRP) released its earnings results on Thursday, February, 27th. The company reported ($30.30) earnings per share for the quarter, topping analysts' consensus estimates of ($30.80) by $0.50.
View Verona Pharma plc (VRP.L)'s earnings history.

Who are Verona Pharma plc (VRP.L)'s key executives?

Verona Pharma plc (VRP.L)'s management team includes the following people:

• Dr. Jan-Anders Karlsson, CEO & Exec. Director (Age 64)
• Mr. Piers John Morgan, Chief Financial Officer (Age 53)
• Ms. Claire Louise Poll L.C.S.W., B.A., B Juris, LLB, ASIA, Gen. Counsel (Age 52)
• Ms. Victoria Stewart, Director of Communications
• Dr. Peter Spargo, Sr. VP of Chemistry Manufacturing & Controls (Age 57)

Who are some of Verona Pharma plc (VRP.L)'s key competitors?

Some companies that are related to Verona Pharma plc (VRP.L) include Biotest Aktiengesellschaft (BIO), MorphoSys (MOR), PureTech Health (PRTC), Ergomed (ERGO), Silence Therapeutics (SLN), Oxford Biomedica (OXB), Pfenex (PFNX), Inventiva (IVA), ProMetic Life Sciences (PLI), Horizon Discovery Group plc (HZD.L) (HZD), Dyne Therapeutics (DYN), Theratechnologies (TH), VIVO Cannabis (ABCN), Precigen (PGEN) and Emblem (EMC).
View all of VRP's competitors.

What other stocks do shareholders of Verona Pharma plc (VRP.L) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Verona Pharma plc (VRP.L) investors own include Verona Pharma (VRNA), Fate Therapeutics (FATE), Pluristem Therapeutics (PSTI), AbbVie (ABBV), BioMarin Pharmaceutical (BMRN), Exelixis (EXEL), Amicus Therapeutics (FOLD), Global Blood Therapeutics (GBT), Grifols (GRFS) and Innoviva (INVA).

What is Verona Pharma plc (VRP.L)'s stock symbol?

Verona Pharma plc (VRP.L) trades on the London Stock Exchange (LON) under the ticker symbol "VRP."

How do I buy shares of Verona Pharma plc (VRP.L)?

Shares of VRP and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Verona Pharma plc (VRP.L)'s stock price today?

One share of VRP stock can currently be purchased for approximately GBX 55.

How much money does Verona Pharma plc (VRP.L) make?

Verona Pharma plc (VRP.L) has a market capitalization of £228.00 million.

How many employees does Verona Pharma plc (VRP.L) have?

Verona Pharma plc (VRP.L) employs 22 workers across the globe.

What is Verona Pharma plc (VRP.L)'s official website?

The official website for Verona Pharma plc (VRP.L) is www.veronapharma.com.

How can I contact Verona Pharma plc (VRP.L)?

Verona Pharma plc (VRP.L)'s mailing address is 3 More London Riverside, LONDON, SE1 2RE, United Kingdom. The company can be reached via phone at +44-20-32834200.